Bristol-Myers Recalls Cancer Drug Due To Overfilled Vial

Law360, New York (August 30, 2012, 4:54 PM EDT) -- Bristol-Myers Squibb Co. is recalling more than 31,000 units of cancer medicine BiCNU after discovering an overfilled vial during routine testing, the pharmaceutical giant said Thursday.

The recall affects 10 lots of BiCNU, an injection of the drug carmustine, which is used to treat brain tumors, multiple myeloma, Hodgkin lymphoma and non-Hodgkin lymphoma. The lots were supplied by Ben Venue Laboratories, a contract manufacturer in Bedford, Ohio.

“An overfilled vial of BiCNU represents a significant risk to patients due to the nature of product administration and...
To view the full article, register now.